Tumorigenicity of EBV-carrying lymphoblastoid cell lines (LCLS): Distinctive grading in scid mice

This publication has 16 references indexed in Scilit:

• The SCID Mouse Mutant: Definition, Characterization, and Potential Uses
  Annual Review of Immunology, 1991
• Rearrangement of T Cell Receptor Delta Genes in Thymus of Scid Mice
  Published by Springer Nature ,1989
• Selective acceptance of MHC class I-deficient tumor grafts in the brain.
  The Journal of Experimental Medicine, 1988
• Expression of the bla antigen, defined by the monoclonal 38.13 antibody, on burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other b-cell lymphomas and leukemias
  International Journal of Cancer, 1983
• Growth of diploid, epstein-barr virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions
  International Journal of Cancer, 1979
• Decline of Natural Killer Cell Activity in Sublethally Irradiated Mice2
  JNCI Journal of the National Cancer Institute, 1978
• Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains
  International Journal of Cancer, 1976
• An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by in vitro Infection
  Intervirology, 1975
• Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells
  Science, 1967
• VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
  The Lancet, 1964